{"prompt": "['PREDM', 'Page 68', 'Drugs with Potential to Reduce Metformin', 'Pyrimethamine', 'Clearance', 'Quinidine', 'Quinine', 'Cationic drugs eliminated by renal tubular', 'Ranitidine', 'secretion (OCT-2 and MATE inhibitors)', 'Ranolazine', '(will be tracked on study and consultation', 'Triamterene', 'with pharmacy regarding need to dose', 'Trimethoprim', 'adjustment if eGFR <90 ml/min/m\u00b2):', 'Vancomycin', 'Amiloride', 'Vandetanib', 'Atenolol', 'Cephalexin', 'Other Drugs with Theoretical Increase in', 'Cimetidine', 'Risk for Lactic Acidosis', 'Digoxin', 'Dolutegravir', 'Carbonic Anhydrase Inhibitors', 'Erlotinib', '(will be tracked on study):', 'Gefitinib', 'Imatinib', 'Topiramate', 'Morphine', 'Zonisamide', 'Nilotinib', 'Acetazolamide', 'Procainamide', 'Dichlorphenamide', 'Proton pump inhibitors (PPIs)', 'Initial version, dated: 04-10-20', 'IRB approkB', \"St. Jude date Children's Research Hospital\", 'NUMBER: 20-0550', 'Protocol document date: 10-12-2020', 'IRB APPROVAL DATE: 11/10/2020']\n\n###\n\n", "completion": "END"}